We lack evidence that end-organ resistance to FGF23 actions on the kidney in Hyp;Fgfr1Dmp1-cKO-null mice, since this would lead to hyperphosphatemia and elevated FGF23 levels, a phenotype different from the one observed in these mice. This evidence concerns the gene FGF23 and hyperphosphatemia.